HomeCompareFICV vs ABBV

FICV vs ABBV: Dividend Comparison 2026

FICV yields 18.67% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ABBV wins by $35.0K in total portfolio value· pulled ahead in Year 8
10 years
FICV
FICV
● Live price
18.67%
Share price
$10.71
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$67.3K
Annual income
$5,834.47
Full FICV calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — FICV vs ABBV

📍 ABBV pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFICVABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FICV + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FICV pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FICV
Annual income on $10K today (after 15% tax)
$1,587.30/yr
After 10yr DRIP, annual income (after tax)
$4,959.30/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, ABBV beats the other by $16,096.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FICV + ABBV for your $10,000?

FICV: 50%ABBV: 50%
100% ABBV50/50100% FICV
Portfolio after 10yr
$84.8K
Annual income
$15,303.12/yr
Blended yield
18.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

FICV
No analyst data
Altman Z
3.2
Piotroski
3/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FICV buys
0
ABBV buys
0
No recent congressional trades found for FICV or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFICVABBV
Forward yield18.67%3.06%
Annual dividend / share$2.00$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.6%
Portfolio after 10y$67.3K$102.3K
Annual income after 10y$5,834.47$24,771.77
Total dividends collected$36.9K$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FICV vs ABBV ($10,000, DRIP)

YearFICV PortfolioFICV Income/yrABBV PortfolioABBV Income/yrGap
1$12,567$1,867.41$11,550$430.00+$1.0KFICV
2$15,640$2,193.32$13,472$627.96+$2.2KFICV
3$19,286$2,551.07$15,906$926.08+$3.4KFICV
4$23,576$2,939.95$19,071$1,382.55+$4.5KFICV
5$28,585$3,358.78$23,302$2,095.81+$5.3KFICV
6$34,392$3,805.99$29,150$3,237.93+$5.2KFICV
7$41,079$4,279.58$37,536$5,121.41+$3.5KFICV
8← crossover$48,732$4,777.26$50,079$8,338.38$1.3KABBV
9$57,440$5,296.48$69,753$14,065.80$12.3KABBV
10$67,295$5,834.47$102,337$24,771.77$35.0KABBV

FICV vs ABBV: Complete Analysis 2026

FICVStock

Frontier Investment Corp does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to search in the technology, digital media, e-commerce, financial technology, and digital services sectors in the Middle East, North Africa, Turkey, Sub-Saharan Africa, and South and Southeast Asia. Frontier Investment Corp was incorporated in 2021 and is based in Wilmington, Delaware.

Full FICV Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this FICV vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FICV vs SCHDFICV vs JEPIFICV vs OFICV vs KOFICV vs MAINFICV vs JNJFICV vs MRKFICV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.